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Introduction 
Chronic Obstructive Pulmonary Disease (COPD) is a condition characterized by progressive 
and persistent airflow limitation resulting from a chronic inflammatory response of the airways 
and lungs in response to inhaled harmful gases and particles. Clinical diagnosis is based on 
airflow obstruction (assessed with lung function test-spirometry) and symptoms. Its prognosis 
depends on several factors including acute exacerbations (define as worsening of symptoms 
that result in additional therapy), environmental exposures, comorbidities and genetic 
predisposition [1]. COPD is burdensome not only for health, economic and social systems but 
most importantly to patients since it significantly affect their quality of life. It is known that the 
disease does not progress in the same way in all patients and that lung function, symptoms and 
reduction of quality of life may not be correlated. In fact, the interplay between patients’ clinical 
characteristics and different disease phenotypes is not fully understood. 
This study aimed to enhance our knowledge on the clinical characteristics of patients with 
COPD. We retrospectively reviewed 394 patients with COPD referred from hospitals and 
primary care centers in the north and center regions of Portugal. The clinical data were acquired 
in the hospitals, primary care centers or in the Respiratory Research and Rehabilitation 
Laboratory (Lab3R), of the School of Health Sciences, University of Aveiro, under the project 
GENIAL. 
 
Methods 
A clustering procedure is designed to stratify patients with COPD. From the 70 registered 
variables, we focus on the most commonly assessed clinical variables: age, the Charlson 
comorbidity index (CCI), body mass index (BMI), forced expiratory volume in one second 
(FEV1.pp), hospitalization by respiratory cause (N.hospit), number of acute exacerbations 
(AECOPD), St. George's Respiratory Questionnaire (SGRQ), the modified British Medical 
Research Council questionnaire (mMRC.score), Hospital Anxiety and Depression Scale 
(HADS.anx and HADS.depr), COPD assessment test total score (CAT.total), quadriceps muscle 
strength (QMS.pp), maximal inspiratory pressure (MIP.pp), maximal expiratory pressure 
  
(MEP.pp), and 1-minute sit-to-stand test (1STS.pp). The suffix “pp” denotes percentage 
predicted, according to gender, age and weight. Clustering aims to find groups in a dataset. 
Since k-medoids looks for spherical clusters, it works best when the input variables are 
uncorrelated and have similar scales. We apply Principal Component (PC) Analysis on these 
vectors, obtaining a set of linearly uncorrelated variables. The number of components to retain 
is selected such that at least a given percentage of the variance is explained. Scores associated 
to those first PCs yield a data matrix, on which a partition clustering algorithm was applied. The 
result of the partition algorithm depends on the number of clusters n, which is often hard to 
choose a priori. Therefore it is common practice to run the method for several values of n, and 
then select the “best” value of n as the one which optimizes a certain criterion called a validity 
index. Many such indices have been proposed in the literature. Here we consider the GAP 
statistic [2].  
 
Results 
In our dataset several variables were strongly correlated, e.g., the Pearson correlation between 
CAT and SGRQ was 0.79. The PC allows obtaining a set of linearly uncorrelated variables. Our 
procedure retained 5 principal components that explained around 70% of the total variance of 
the dataset. Carrying out k-medoids clustering for different numbers of clusters and evaluating 
the obtained validation indices it appears that four clusters are appropriate (GAP = 0.697± 
0.015, for 500 bootstrap samples). By looking at the composition of each cluster we define a 
patient profile of each cluster. It was observed that older patients present more comorbidities 
than younger patients and that marked differences exist in patients’ symptoms, functionality and 
quality of life independently of patient’s age and comorbidities (Figure 1). 
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Figure 1. Clinical characteristics of patients allocated to each of the four clusters. The thick line within 
each box points the median of each cluster of patients in the following variables: age, the Charlson 
comorbidity index (CCI), body mass index (BMI), forced expiratory volume in one second (FEV1.pp), 
hospitalization by respiratory cause (N.hospit), number of acute exacerbations (AECOPD), St. George's 
Respiratory Questionnaire (SGRQ), the modified British Medical Research Council questionnaire 
(mMRC.score), Hospital Anxiety and Depression Scale (HADS.anx and HADS.depr), COPD assessment 
test total score (CAT.total), quadriceps muscle strength (QMS.pp), maximal inspiratory pressure (MIP.pp), 
maximal expiratory pressure (MEP.pp), and 1-minute sit-to-stand test (1STS.pp). The suffix “pp” denotes 
percentage predicted. 
 
 
Discussion and conclusions 
We found four clusters of COPD patients. There are two clusters of older patients and two of 
younger patients and within these clusters two opposite profiles of very symptomatic and not 
very symptomatic. It is now intended to validate the clinical profiles with an external sample of 
patients that has not been used to create the clusters. 
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